Advertisement

Britain’s £72 billion under-the-radar success story: CNBC UK Exchange

This report is from this week’s CNBC’s UK Exchange newsletter by Ian King. Like what you see? You can subscribe here.

The dispatch

One of the City’s most prominent investment bankers recently spelled out to me the challenges, as he saw them, faced by the U.K. economy.

He argued that, as a country, Britain does not really make much that the rest of the world wants to buy from us these days, aside from a few honorable exceptions, including cars, luxury goods, aerospace and defense components and Scotch whisky.

Meanwhile, he went on, sectors where the U.K. was once a world leader, such as financial services, have not really recovered from the global financial crisis (although he might have added, in the wake of last week’s Mansion House speech, that the government has at least recognized the extent to which post-crisis regulation is holding back the sector).

So what, he asked, are the strengths that the U.K. economy still enjoys? Put on the spot, I suggested a world-class life sciences sector, a world-leading legal and professional services sector and some of the globe’s greatest universities.

Britain's Chancellor of the Exchequer Rachel Reeves (C) reacts during a visit to the Sir Ludwig Guttmann Health and Wellbeing Centre in east London on July 3, 2025, where they launched the Government's new Health Plan.

The UK’s budget gap is widening and markets want to know Reeves’ fix

AI boom

One of the more remarkable things about this company is where it has come from.

Previously called Reed Elsevier (it rebranded itself as RELX in February 2015), it was formed in 1993 by the merger of Elsevier, a Dutch scientific publisher with Reed International, a British company which in the 1970s was best known as one of the country’s biggest publishers of newspapers — including the Daily Mirror — magazines and comics.

The latter included titles such as Whizzer and Chips and Roy of the Rovers that generations of British schoolchildren grew up reading.

Remarkably, at the turn of the century, it was generating nearly two-thirds of its revenues from print products, but over the subsequent decade migrated most of its business to electronic media. Print now accounts for just 4% of revenues.

The journey has not been without bumps in the road, most notably when, in November 2009, it replaced Ian Smith, its then chief executive, just eight months after he had succeeded Crispin Davis, the long-running CEO who had begun equipping the business for the digital era.

Smith’s successor Erik Engstrom, a former Elsevier CEO, has been in the job ever since and has built the business both organically and by regular bolt-on acquisitions, including five last year alone.

He has also been unafraid to dispose of businesses at times. What has really excited investors is that the business is seen as one of the big winners from the artificial intelligence boom. It began incorporating AI into its products more than a decade ago and AI is now embedded in many of them.

For example, at the full-year results in February, Engstrom noted that, in the risk division, more than 90% of divisional revenues come from machine-to-machine interactions.

In legal, it is busy rolling out Lexis+AI, which it claims is the world’s first generative AI platform for the legal profession.

Similarly, in STM, the company has launched a workflow product called ScienceDirect AI, which helps researchers instantly access relevant copy from peer-reviewed research articles and book chapters as they conduct investigations.

It is also helping scientific publishers tackle integrity issues — something increasingly important in a world where misinformation and disinformation risk undermining confidence in research.

All this investment — it is one of the top 10 spenders on research and development in the FTSE-100 — gives the company a legitimate claim to be one of the U.K.’s biggest tech companies even though it is traditionally thought of as a publisher.

Yet, there is also an argument that RELX, like competitors such as Wolters Kluwer (in scientific publishing) and Thomson Reuters (in risk and legal) needs to keep investing heavily to stay ahead, while in science in particular there is growing competition from open-source repositories such as arXiv and SSRN.

Corners of academia have long groused about the amount of money university libraries must pay companies like RELX and a campaign, the Cost of Knowledge, was organized some years ago in an attempt to get academics to boycott Elsevier.

The University of California Los Angeles briefly cancelled its contract with the company in 2019. All that said, RELX is still the very definition of what investors call a “quality compounder” — a business that consistently reinvests at a high return on capital.

Other examples in the FTSE-100 include Experian, another global data provider and Halma, the safety and healthcare technology company. They are exactly the kind of businesses with which the U.K. is earning its living in the world in the 21st century.

— Ian King

Top TV picks on CNBC

Need to know

In the markets

https://image.cnbcfm.com/api/v1/image/108175080-1753192053608-gettyimages-2211253066-250425_lseg_02.jpeg?v=1753192090&w=1920&h=1080

2025-07-23 00:30:01

Leave a Reply

Your email address will not be published. Required fields are marked *

Social Media Auto Publish Powered By : XYZScripts.com